Risk factors for 1-year relapse of pulmonary tuberculosis treated with a 6-month daily regimen

Respiratory Medicine

Volumn 108, Issue 4, 2014, Pages 654-659

  Jo, Kyung Wook ^a   Yoo, Jung Wan ^a   Hong, Yoonki ^b   Lee, Jae Seung ^a   Lee, Sang Do ^a   Kim, Woo Sung ^a   Kim, Dong Soon ^a   Shim, Tae Sun ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

2 Month culture conversion; Cavity; Pulmonary tuberculosis; Relapse

Indexed keywords

ETHAMBUTOL PLUS ISONIAZID PLUS PYRAZINAMIDE PLUS RIFAMPICIN; ISONIAZID PLUS RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM CULTURE; DRUG SENSITIVITY; FEMALE; HUMAN; LUNG CAVITATION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RECURRENCE RISK; RELAPSE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT OUTCOME; AGED; DRUG ADMINISTRATION; DRUG COMBINATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PROGNOSIS; RADIOGRAPHY; RECURRENT DISEASE; TUBERCULOSIS, PULMONARY;

ADULT; AGED; ANTITUBERCULAR AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 84896070725     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2014.01.010     Document Type: Article

References (25)

1. K.C. Chang, C.C. Leung, W.W. Yew, S.C. Ho, and C.M. Tam A nested case-control study on treatment-related risk factors for early relapse of tuberculosis Am J Respir Crit Care Med 170 2004 1124 1130
2. C.M. Tam, S.L. Chan, K.M. Kam, R.L. Goodall, and D.A. Mitchison Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures Int J Tuberc Lung Dis 6 2002 3 10
3. J. d'Arc Lyra Batista, M. de Fátima Pessoa Militão de Albuquerque, R.A. de Alencar Ximenes, and L.C. Rodrigues Smoking increases the risk of relapse after successful tuberculosis treatment Int J Epidemiol 37 2008 841 851
4. Tuberculosis Research Committee (Ryoken) Relapse rate of tuberculosis treated with standard regimen of chemotherapy Kekkaku 84 2009 617 625
5. C.R. Driver, S.S. Munsiff, J. Li, N. Kundamal, and S.S. Osahan Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City Clin Infect Dis 33 2001 1762 1769
6. D. Benator, M. Bhattacharya, and L. Bozeman et al. Tuberculosis Trials Consortium. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomized clinical trial Lancet 360 2002 528 534
7. D.A. Mitchison Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months Am Rev Respir Dis 147 1993 1062 1063
8. K.C. Chang, C.C. Leung, W.W. Yew, S.L. Chan, and C.M. Tam Dosing schedules of 6-month regimens and relapse for pulmonary tuberculosis Am J Respir Crit Care Med 174 2006 1153 1158
9. M. Zierski, E. Bek, M.W. Long, and D.E. Snider Jr. Short-course (6 month) cooperative tuberculosis study in Poland: results 18 months after completion of treatment Am Rev Respir Dis 122 1980 879 889
10. Hong Kong Chest Service/Tuberculosis Research Centre Madras/British Medical Research Council. A controlled clinical comparison of 6 and 8 months of antituberculosis chemotherapy in the treatment of patients with silicotuberculosis in Hong Kong Am Rev Respir Dis 143 1991 262 267
11. M. Zierski, E. Bek, M.W. Long, and D.E. Snider Jr. Short-course (6-month) cooperative tuberculosis study in Poland: results 30 months after completion of treatment Am Rev Respir Dis 124 1981 249 251
12. D. Menzies, A. Benedetti, and A. Paydar et al. Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis Plos Med 6 2009 e1000146
13. V.R. Aber, and A.J. Nunn Factors affecting relapse following short-course chemotherapy Bull Int Union Tuberc 53 1978 276 280
14. American Thoracic Society/Centers for disease control and Prevention/Infectious diseases Society of America Treatment of tuberculosis Am J Respir Crit Care Med 167 2003 603 662
15. Treatment of tuberculosis guidelines 4th ed. 2009 World Health Organization
16. Korean guideline for tuberculosis. Available at: http://www.lungkorea. org/image/mail/file-110217.pdf [assessed May 2013].
17. J.S. Park Increasing the treatment success rate of tuberculosis in a private hospital through Public-Private Mix (PPM) project Tuberc Respir Dis 70 2011 143 169
18. National Tuberculosis Association Diagnostic standards and classification of tuberculosis 1961 The National Tuberculosis Association New York
19. F.M. Perrin, N. Woodward, and P.P. Phillips et al. Radiological cavitation, sputum mycobacterial load and treatment response in pulmonary tuberculosis Int J Tuberc Lung Dis 14 2010 1596 1602
20. S.M. Dembele, H.Z. Ouedraogo, A. Combary, N. Saleri, J. Macq, and B. Dujardin Conversion rate at two-month follow-up of smear-positive tuberculosis patients in Burkina Faso Int J Tuberc Lung Dis 11 2007 1339 1344
21. K.J. Seung, G.H. Bai, S.J. Kim, W.J. Lew, S.K. Park, and J.Y. Kim The treatment of tuberculosis in South Korea Int J Tuberc Lung Dis 7 2003 912 919
22. E. Bae, J.H. Im, and S.W. Kim et al. Evaluation of combination of BACTEC mycobacteria growth indicator tube 960 system and Ogawa media for mycobacterial culture Korean J Lab Med 28 2008 299 306
23. T.S. Shim, M.-N. Kim, and C.M. Choi et al. Impact of additional use of liquid media on the treatment of pulmonary tuberculosis Proceedings of the 40th world conference on lung health of the international union against tuberculosis and lung disease (The union); 2009 Dec 3-7; Cancun, Mexico 2009 S347
24. M.L. Lambert, E. Hasker, A. Van Deun, D. Roberfroid, M. Boelaert, and P. Van der Stuyft Recurrence in tuberculosis: relapse or reinfection? Lancet Infect Dis 3 2003 282 287
25. C.H. Lee, J.Y. Hwang, and J.Y. Bae et al. HIV/tuberculosis co-infection in Korea [abstract] Tuberc Respir Dis 61 2007 62